Literature DB >> 3050249

Creatinine measurements often yielded false estimates of progression in chronic renal failure.

M Walser1, H H Drew, N D LaFrance.   

Abstract

In 9 of 22 observation periods (lasting an average of 15 months) in 17 patients with moderate to severe chronic renal failure (GFR 4 to 23 ml/min), rates of progression as estimated from the linear regression on time of 24-hour creatinine clearance (b1) differed significantly from rates of progression as estimated from the regression on time of urinary clearance of 99mTc-DTPA (b2), during all or part of the period of observation. b1 exceeded b2 in four cases and was less than b2 in the other five. Thus there were gradual changes in the fractional tubular secretion of creatinine in individual patients, in both directions. Owing to these changes, measurements of creatinine clearance gave erroneous impressions of the rate or existence of progression during all or a portion of the period of observation in nearly half of these patients. In the 22 studies as a group, using the entire periods of observation, b1 indicated significantly more rapid progression (by 0.18 +/- 0.06 ml/min/month, P less than 0.01) than did b2, and had a significantly greater variance. Measurements of progression based on the rate of change of reciprocal plasma creatinine (multiplied by an average rate of urinary creatinine excretion in each study) were equally misleading, even though less variable. We conclude that sequential creatinine measurements are often misleading as measures of progression and should, when feasible, be replaced by urinary clearance of isotopes in following patients with chronic renal failure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3050249     DOI: 10.1038/ki.1988.196

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  12 in total

Review 1.  Measurement of renal function during drug development.

Authors:  D Craig Brater
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  Nephrology, dialysis and transplantation.

Authors:  K Farrington; P Sweny
Journal:  Postgrad Med J       Date:  1990-07       Impact factor: 2.401

3.  Effects of a new amino acid supplement on blood AA pools in patients with chronic renal failure.

Authors:  G Garibotto; G Deferrari; C Robaudo; S Saffioti; M R Sala; E Paoletti; A Tizianello
Journal:  Amino Acids       Date:  1991-10       Impact factor: 3.520

4.  Creatinine, body size and renal function.

Authors:  G B Haycock
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

5.  Expressing glomerular filtration rate in children.

Authors:  D C Heilbron; M A Holliday; A al-Dahwi; B A Kogan
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

Review 6.  Do glomerular hemodynamic adaptations influence the progression of human renal disease?

Authors:  A S Woolf; L G Fine
Journal:  Pediatr Nephrol       Date:  1991-01       Impact factor: 3.714

7.  Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study.

Authors:  Amanda Hyre Anderson; Wei Yang; Chi-yuan Hsu; Marshall M Joffe; Mary B Leonard; Dawei Xie; Jing Chen; Tom Greene; Bernard G Jaar; Patricia Kao; John W Kusek; J Richard Landis; James P Lash; Raymond R Townsend; Matthew R Weir; Harold I Feldman
Journal:  Am J Kidney Dis       Date:  2012-06-02       Impact factor: 8.860

8.  Quantitative analysis of drug handling by the kidney using a physiological model of renal drug clearance.

Authors:  I Janků; K Zvára
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

9.  Validation of the Center for Medicare and Medicaid Services algorithm for eligibility for dialysis.

Authors:  Mouin G Seikaly; Samer Loleh; Alex Rosenblum; Richard Browne
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

10.  Effect of cyclosporine A on long-term allograft function in pediatric renal transplant recipients.

Authors:  A W Williams; B Z Morgenstern; M Murphy; D S Milliner
Journal:  Pediatr Nephrol       Date:  1994-10       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.